Stockreport

Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024

Biodesix, Inc.  (BDSX) 
PDF BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that it will rel [Read more]